Skip to main content
SpringerLink
Log in

Interferon-Β-1b reimbursable for MS patients in Canada

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Interferon-Β-1b reimbursable for MS patients in Canada. Pharmacoecon. Outcomes News 247, 11 (2000). https://doi.org/10.1007/BF03266818

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03266818

Keywords

Search

Navigation